We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.6B
AUM Growth
+$641M
Cap. Flow
-$977M
Cap. Flow %
-3.68%
Top 10 Hldgs %
20.63%
Holding
2,354
New
199
Increased
638
Reduced
849
Closed
186

Top Buys

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$52.3M
2
WELL icon
Welltower
WELL
+$43.3M
3
UBER icon
Uber
UBER
+$40.2M
4
EQH icon
Equitable Holdings
EQH
+$39.3M
5
SPG icon
Simon Property Group
SPG
+$35.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$61.1M
2
MSFT icon
Microsoft
MSFT
+$58M
3
MS icon
Morgan Stanley
MS
+$49.1M
4
ATVI
Activision Blizzard
ATVI
+$45.9M
5
ABT icon
Abbott
ABT
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Financials 15.99%
3 Healthcare 12.36%
4 Consumer Discretionary 11.1%
5 Communication Services 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRCA icon
2151
Verrica Pharmaceuticals
VRCA
$86.2M
$4K ﹤0.01%
30
VXRT
2152
DELISTED
Vaxart
VXRT
$4K ﹤0.01%
700
WSFS icon
2153
WSFS Financial
WSFS
$4.1B
$4K ﹤0.01%
100
MTVA
2154
MetaVia Inc
MTVA
$7.64M
0
DCPH
2155
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
100
RDUS
2156
DELISTED
Radius Health, Inc.
RDUS
$4K ﹤0.01%
200
PAE
2157
DELISTED
PAE Incorporated Class A Common Stock
PAE
$4K ﹤0.01%
500
-14,700
-97% -$131K
BLPH
2158
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4K ﹤0.01%
900
EVTC icon
2159
Evertec
EVTC
$1.83B
$3K ﹤0.01%
100
ZYXI
2160
DELISTED
Zynex
ZYXI
$3K ﹤0.01%
+220
New +$3.36K
GLNG icon
2161
Golar LNG
GLNG
$4.95B
$2K ﹤0.01%
200
SVRA icon
2162
Savara
SVRA
$1.13B
$1K ﹤0.01%
800
XERS icon
2163
Xeris Biopharma Holdings
XERS
$1.44B
$1K ﹤0.01%
300
KBAL
2164
DELISTED
Kimball International
KBAL
$1K ﹤0.01%
100
AC
2165
DELISTED
Associated Capital Group
AC
-2,900
Closed -$101K
ACWX icon
2166
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
-214,471
Closed -$11.4M
ADMA icon
2167
ADMA Biologics
ADMA
$1.92B
$0 ﹤0.01%
400
ADTN icon
2168
Adtran
ADTN
$798M
-52,400
Closed -$773K
AKRO
2169
DELISTED
Akero Therapeutics
AKRO
-2,600
Closed -$67K
ALGS icon
2170
Aligos Therapeutics
ALGS
$25.2M
-100
Closed -$69K
ALLO icon
2171
Allogene Therapeutics
ALLO
$601M
-12,500
Closed -$315K
ANIP icon
2172
ANI Pharmaceuticals
ANIP
$1.77B
-21,700
Closed -$630K
APLS
2173
DELISTED
Apellis Pharmaceuticals
APLS
-3,400
Closed -$194K
AR icon
2174
Antero Resources
AR
$10.9B
-9,500
Closed -$51K
ARCT icon
2175
Arcturus Therapeutics
ARCT
$157M
-1,100
Closed -$47K

Similar funds

STRS Ohio's Q1 2021 Portfolio in Review

As of Q1 2021, STRS Ohio held 2,354 positions worth $26.6B, up 2.5% from $25.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

STRS Ohio withdrew a net $977M in Q1 2021, closing 186 positions and reducing 849 holdings. Its most notable exit was iShares MSCI China ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, STRS Ohio opened a new position in Jones Lang LaSalle worth $28.7M.

  • STRS Ohio's largest Q1 2021 buy was Jones Lang LaSalle: 160,344 shares worth $28.7M.
  • STRS Ohio added most to Cintas in Q1 2021, an estimated $52.3M increase.
  • STRS Ohio's biggest Q1 2021 reduction was Apple, cutting an estimated $61.1M.
  • STRS Ohio fully exited iShares MSCI China ETF in Q1 2021, selling an estimated $25.9M.
  • STRS Ohio's ten largest holdings make up 21% of its $26.6B portfolio in Q1 2021.
  • STRS Ohio opened 199 new positions and closed 186 in Q1 2021.
  • STRS Ohio's portfolio value rose 2.5% quarter-over-quarter to $26.6B.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.